High fluorescence cells in pleural fluid. Association with pleural malignancy

D. Badenes, A. Supervía, F. Del Baño, S. Herrera, C. Vilaplana, T. Torrella, I. Cirera, O. Pallás (Barcelona, Spain)

Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Session: Clinical problems in mediastinal and pleural malignacies
Session type: Poster Discussion
Number: 3075
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Badenes, A. Supervía, F. Del Baño, S. Herrera, C. Vilaplana, T. Torrella, I. Cirera, O. Pallás (Barcelona, Spain). High fluorescence cells in pleural fluid. Association with pleural malignancy. Eur Respir J 2013; 42: Suppl. 57, 3075

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association of biochemical determinants and fibrinous formation in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015



Role of thoracoscopic pleural lavage and brush in undiagnosed exudative pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Yield of pleural cytology and macroscopic pleural invasion in metastatic pleural effusion
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


1,25-dihydroxyvitamin D in malignant and non-malignant pleural effusions
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013


Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006

Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy?
Source: Eur Respir J 2006; 28: Suppl. 50, 783s
Year: 2006

Malignant pleural effusion and incidence of pleural thickening in thorax CT
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Comparison of multiple serum and pleural fluid biomarkers for the diagnosis of Malignant Pleural Mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Diagnostic accuracy of pleural fluid cytology compared to pleural biopsy histology obtained via thoracoscopy
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Role of Dr-70 immunoassay in suspected malignant pleural effusion
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Metastatic pleural effusions (mpes)
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008


Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012